Unlock instant, AI-driven research and patent intelligence for your innovation.

5‑amino‑quinoline‑8‑carboxamide derivatives as 5‑ht4 receptor agonists

A technology of formamide and amino, applied in the field of new quinoline compounds of formula and their pharmaceutically acceptable salts

Inactive Publication Date: 2017-12-08
SUVEN LIFE SCI LTD
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although several 5-HT 4 Agonists / partial agonists, but so far not targeting 5-HT 4 Compounds (whether agonists or partial agonists) of the receptor are marketed for the treatment of dementia-related diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 5‑amino‑quinoline‑8‑carboxamide derivatives as 5‑ht4 receptor agonists
  • 5‑amino‑quinoline‑8‑carboxamide derivatives as 5‑ht4 receptor agonists
  • 5‑amino‑quinoline‑8‑carboxamide derivatives as 5‑ht4 receptor agonists

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0447] Example 1: 5-amino-6-chloro-N-{[1-(tetrahydro-2H-pyran-4-ylmethyl)-4-piperidinyl]methyl}quinoline-8-carboxamide Preparation of hemifumarate

[0448]

[0449] Step (i): 5-Amino-6-chloro-N-{[1-(tetrahydro-2H-pyran-4-ylmethyl)-4-piperidinyl]methyl}quinoline-8-methanol Preparation of amides

[0450]

[0451] 5-Amino-6-chloro-N-[(4-piperidinyl)methyl]quinoline-8-carboxamide (5.60 g, 0.017 mol, obtained from Preparation 2) and tetrahydropyran-4-carbaldehyde (2.40 g, 0.021 mol) in dichloroethane (70 mL) was cooled to 10°C. Sodium triacetoxyborohydride (7.45 g, 0.035 mol) was added to the above reaction mass. It was further stirred overnight at RT while monitoring the progress of the reaction by TLC. After completion of the reaction (TLC), the reaction mass was concentrated and the slurry thus obtained was quenched in water (150 mL). The pH of the resulting material was adjusted to ~9.5 using aqueous ammonia and the product was extracted with DCM (3 x 100 mL). The c...

Embodiment 2

[0460] Example 2: 5-amino-6-chloro-N-{[3-(tetrahydro-2H-pyran-4-ylmethyl)-3-azabicyclo[3.1.0]hex-6-yl] Preparation of Methyl}quinoline-8-carboxamide L(+)-tartrate

[0461]

[0462] Step (i): 5-amino-6-chloro-N-{[3-(tetrahydro-2H-pyran-4-ylmethyl)-3-azabicyclo[3.1.0]hex-6-yl Preparation of ]methyl}quinoline-8-carboxamide

[0463]

[0464] 5-Amino-6-chloro-N-{[3-azabicyclo[3.1.0]hex-6-yl]methyl}quinoline-8-carboxamide (0.30 g, 0.947 mmol, obtained from 4) and tetrahydropyran-4-carbaldehyde (0.14 g, 1.228 mmol) in dichloroethane (30 mL) were cooled to 10°C and treated with sodium triacetoxyborohydride (0.40 g, 1.886 mmol). The reaction mass was stirred overnight at RT while monitoring the progress of the reaction by TLC. After the reaction was complete (TLC), the reaction mass was poured into (40 mL). The pH of the resulting material was adjusted to ~9.5 with aqueous ammonia and the product was extracted with DCM (3 x 25 mL). The combined organic phases were washed wit...

Embodiment 3 to 19

[0473] The compounds of Examples 3 to 19 were prepared by following the experimental procedure described in Examples 1 to 2 given above with some non-critical changes.

[0474]

[0475]

[0476]

[0477]

[0478]

[0479]

[0480]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a novel quinoline compound of formula (I) and a pharmaceutically acceptable salt thereof and a preparation method thereof. Compounds of formula (I) can be used to treat various diseases related to 5‑HT4 receptor agonists.

Description

technical field [0001] The present invention relates to the new quinoline compound of formula (I) and pharmaceutically acceptable salt thereof, and it is used for the treatment and 5-HT 4 A variety of diseases associated with receptor agonists. [0002] Background technique [0003] 5-HT 4 receptor (5-HT 4 R) Belongs to the serotonin (5-HT) receptor superfamily and positively couples to adenylate cyclase to increase cAMP production. 5-HT 4 R is widely expressed throughout the body, but of all species studied so far, the highest densities of 5-HT are observed in learning-related brain regions such as the cortex and hippocampus 4 R (Lezoualc'h, F et al. The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics, The Humana Press, Chapter 15, 2006, 459-479). Brain microdialysis has shown that intraventricular injection of 5-HT 4 Acetylcholine release is increased in rat frontal cortex and hippocampus following R agonists (Journal of Pharmacology and Exp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D405/14C07D401/12A61K31/4709A61P25/00A61P1/00
CPCG01N33/57426G01N2333/82G01N2800/52C07D401/12C07D405/14A61P1/00A61P25/00A61P25/04A61P25/14A61P25/16A61P25/18A61P25/24A61P25/28A61P43/00Y02A50/30
Inventor 罗摩克里希纳·尼罗吉阿尼尔·卡巴里·欣德文卡特斯瓦卢·贾斯蒂
Owner SUVEN LIFE SCI LTD